Insulet (PODD) Change in Accured Expenses (2010 - 2026)

Insulet (PODD) has 17 years of Change in Accured Expenses data on file, last reported at -$69.3 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 42.59% year-over-year to -$69.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.5 million (up 2281.36% YoY) and the FY2025 annual result came in at $161.2 million, up 2140.51% from the prior year.
• Change in Accured Expenses fell to -$69.3 million in Q1 2026, from $161.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $161.3 million in Q4 2025 to a low of -$69.3 million in Q1 2026.
• A 5-year average of $12.6 million and a median of -$4.2 million in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 12033.33% — and 2025, when it jumped 1954.02%.
• Tracing PODD's Change in Accured Expenses over 5 years: stood at $132.1 million in 2022, then slumped by 103.18% to -$4.2 million in 2023, then slumped by 107.14% to -$8.7 million in 2024, then jumped by 1954.02% to $161.3 million in 2025, then sank by 142.96% to -$69.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$69.3 million (Q1 2026), $161.3 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.